E-Book, Englisch, 283 Seiten, eBook
Proietti / AlTurki / Ferri Direct Oral Anticoagulants
1. Auflage 2021
ISBN: 978-3-030-74462-5
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark
From Pharmacology to Clinical Practice
E-Book, Englisch, 283 Seiten, eBook
ISBN: 978-3-030-74462-5
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark
This book concisely covers the latest developments in the application of direct oral anticoagulants (DOACs) within cardiovascular medicine. It details the pharmacodynamics and pharmacokinetic mechanisms of DOACs and their application in treating patients with conditions ranging from coronary heart disease through kidney disease and cancer, including their perioperative management.
Direct Oral Anticoagulants: From Pharmacology to Clinical Practice systematically describes the underlying mechanisms associated with DOACs and their use to treat a range of conditions and is an indispensable resource for all trainee and practicing physicians in a range of disciplines seeking a concise up-to-date resource on the topic.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Weitere Infos & Material
Chapter 1. The Coagulative cascadeChapter 2 Clinical Indications for Direct Acting Oral AnticoagulantsChapter 3. Pharmacokinetic and pharmaco-dynamic of DOACChapter 4. Drug-drug interaction with DO-ACsChapter 5. Direct Oral Anticoagulant Reversal for Management of Bleeding and Emergent SurgeryChapter 6. Risk stratification for and use of DOAC therapies for stroke prevention in patient with atrial fibrillationChapter 7. Use of DOAC in patients with kidney diseaseChapter 8. Anticoagulation In Elderly Patients With Atrial FibrallationChapter 9. The “Obesity Paradox” And The Use Of NOACChapter 10. Direct Oral Anticoagulation In Cancer PatientsChapter 11. DOACs and Dementia in Patients with Atrial FibrillationChapter 12. Non-Vitamin K Antagonists and Cardiac Implantable Electronic DevicesChapter 13. Direct Oral Anticoagulants and Atrial Fibrillation AblationChapter 14. DOAC therapy in patients post left atrial appendage occlusion or isolationChapter 15. Use of Direct Oral Anticoagulants after Transcatheter Aortic Valve ReplacementChapter 16. Use of Direct Oral Anticoagulants after Percutaneous Coronary InterventionChapter 17: Direct oral anticoagulants and Left Ventricular Thrombosis: the evidence for a good therapeutic approach




